Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsBiotechnology Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1792741

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1792741

Molecular Pharming

PUBLISHED:
PAGES: 495 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Molecular Pharming Market to Reach US$2.3 Billion by 2030

The global market for Molecular Pharming estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Maize Crop, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$607.4 Million by the end of the analysis period. Growth in the Barley Crop segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$449.8 Million While China is Forecast to Grow at 9.1% CAGR

The Molecular Pharming market in the U.S. is estimated at US$449.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$468.3 Million by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Molecular Pharming Market - Key Trends & Drivers Summarized

What Is Molecular Pharming and Why Is It Gaining Momentum?

Molecular pharming refers to the use of genetically modified plants to produce pharmaceutical substances such as vaccines, antibodies, enzymes, and therapeutic proteins. This technique combines plant biotechnology with pharmaceutical manufacturing, allowing plants to function as biofactories for complex biologics. Molecular pharming is gaining attention for its potential to offer scalable, low-cost, and contamination-resistant alternatives to traditional cell-based or microbial production systems.

By using crops such as tobacco, maize, rice, and even lettuce, researchers can express specific genes that encode therapeutic proteins. These proteins are then harvested and purified for medical use. Molecular pharming is particularly suited for producing biologics in large volumes, especially in low-resource settings or during health emergencies where rapid and cost-effective manufacturing is critical. Its growing relevance lies in its ability to meet rising global demand for biologics while bypassing the limitations of conventional production infrastructure.

How Are Technologies and Processes Advancing in This Field?

Advancements in genetic engineering, plant transformation techniques, and protein expression systems have significantly improved the efficiency and viability of molecular pharming. Technologies such as Agrobacterium-mediated gene transfer, transient expression using viral vectors, and CRISPR-based gene editing are helping optimize yields and reduce development time. Purification processes have also evolved, with new methods enabling the recovery of high-purity proteins without damaging their structure or function.

Innovations now allow expression of monoclonal antibodies, insulin analogs, and enzyme replacement therapies directly within plant tissues. Some approaches use hydroponically grown plants in contained environments to maintain consistency and meet pharmaceutical-grade standards. Regulatory frameworks are gradually adapting to support commercial scale-up, with a few plant-derived biologics already approved for use. These developments are expanding confidence in plant-based production systems, especially for niche or high-volume therapeutic needs.

Where Is Molecular Pharming Being Applied and Who Are the Key Stakeholders?

Molecular pharming is being applied in several areas including vaccine development, infectious disease treatment, cancer therapy, and rare genetic disorders. One of its major successes has been the production of antibodies against Ebola and rabies viruses. Research institutions, biotech firms, and pharmaceutical companies are investing in plant-based platforms to diversify their biologics pipelines and respond to evolving global health priorities.

Academic research centers play a central role in early-stage development and proof-of-concept studies, while private-sector players focus on scale-up, formulation, and regulatory approval. Governments and health organizations in developing regions view molecular pharming as a means to achieve greater self-reliance in essential medicine production. Partnerships between public institutions and biotech companies are becoming more common, especially for producing vaccines and treatments for diseases that lack commercial incentives under traditional models.

What Factors Are Driving Growth In The Molecular Pharming Market?

Growth in the molecular pharming market is driven by several factors including rising demand for biologics, limitations of traditional manufacturing systems, and the need for flexible, scalable production platforms. Molecular pharming offers cost advantages in terms of infrastructure and raw materials, making it attractive for producing affordable therapies in developing countries. The ability to rapidly deploy production in response to emerging infectious diseases is another key benefit driving interest.

Advances in plant biotechnology, increased investment in synthetic biology, and progress in downstream purification technologies are helping overcome past limitations related to yield and consistency. Growing support from regulatory bodies and public health institutions is also encouraging wider adoption. As global healthcare systems look for resilient and decentralized manufacturing solutions, molecular pharming is emerging as a viable approach to meeting future therapeutic needs with greater speed and sustainability.

SCOPE OF STUDY:

The report analyzes the Molecular Pharming market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Crop Source (Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop, Alfalfa Crop); Technology (Gene Gun Technology, Agro infiltration Technology, Electroporation Technology, Agrobacterium-Mediated Gene Transfer Technology, Other Technologies); Application (Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application, Other Applications); End-Use (Biotech & Pharma Companies End-Use, CROs End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

  • Agrenvec S.L.
  • Avaxin Biologics
  • Baiya Phytopharm
  • BioBetter Ltd.
  • Bright Biotech
  • Cape Bio Pharms (Cape Biologix Tech.)
  • Diamante S.r.l.
  • Elo Life Systems
  • Leaf Expression Systems
  • Medicago Inc.
  • Miruku
  • Moolec Science SA
  • MOZZA (Mozza Foods)
  • Nobell Foods
  • ORF Genetics hf.
  • PlantForm Corporation
  • Planet Biotechnology Inc.
  • ProdiGene Inc.
  • Protalix Biotherapeutics, Inc.
  • Tiamat Sciences Corp.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP37427

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Molecular Pharming - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Cost-Effective Biopharmaceuticals Propels Adoption of Molecular Pharming Technologies
    • Rising Interest in Plant-Based Protein Expression Systems Strengthens Business Case for Alternative Drug Production
    • Expansion of Therapeutic Protein and Vaccine Development Drives Innovation in Molecular Pharming Platforms
    • Reduced Risk of Human Pathogen Contamination in Plant Systems Accelerates Regulatory Acceptance
    • Technological Advancements in Gene Editing and Plant Transformation Enhance Efficiency and Product Yield
    • Growth in Monoclonal Antibody Research Fuels Demand for Scalable Plant-Based Expression Systems
    • Increasing Pressure to Lower Biologic Drug Production Costs Spurs Investment in Molecular Pharming Startups
    • Global Vaccine Access Initiatives Highlight Potential of Plant-Derived Vaccines for Rapid, Scalable Deployment
    • Expansion of Biodefense and Pandemic Preparedness Programs Throws Spotlight on Fast-Track Production Methods
    • Growing Need for Cold Chain-Free Biologics Enhances Suitability of Plant-Based Pharmaceutical Products
    • Increased Application of Molecular Pharming in Veterinary Biologics Broadens End-Use Market Scope
    • Demand for Plant-Derived Enzymes and Industrial Proteins Drives Cross-Sector Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Molecular Pharming Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Molecular Pharming by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Maize Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Maize Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Maize Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Barley Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Barley Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Barley Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Tobacco Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Tobacco Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Tobacco Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Safflower Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Safflower Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Safflower Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Rice Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Rice Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Rice Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Alfalfa Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Alfalfa Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Alfalfa Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Agrobacterium-Mediated Gene Transfer Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Agrobacterium-Mediated Gene Transfer Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Agrobacterium-Mediated Gene Transfer Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gene Gun Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gene Gun Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Gene Gun Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Agro infiltration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Agro infiltration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Agro infiltration Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Electroporation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Electroporation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Electroporation Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Recombinant Antibodies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Recombinant Antibodies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Recombinant Antibodies Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Hormones Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Hormones Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Hormones Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Vaccines Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Industrial Enzymes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Industrial Enzymes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Industrial Enzymes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Proteins & Protein-based Materials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Proteins & Protein-based Materials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Proteins & Protein-based Materials Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Technical Reagents Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Technical Reagents Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: World 16-Year Perspective for Technical Reagents Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: World 16-Year Perspective for Biotech & Pharma Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 62: World Recent Past, Current & Future Analysis for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: World Historic Review for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: World 16-Year Perspective for CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 65: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 68: USA Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: USA 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 71: USA Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: USA 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 74: USA Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: USA Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: USA 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 77: USA Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: USA Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: USA 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Canada 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Canada 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 86: Canada Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Canada Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Canada 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 89: Canada Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Canada Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Canada 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Japan 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Japan 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 98: Japan Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Japan Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Japan 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 101: Japan Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Japan Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Japan 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 104: China Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: China 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: China 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: China 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 113: China Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: China Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: China 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Molecular Pharming by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Europe 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Europe 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Europe 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Europe 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Europe 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 131: France Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: France 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: France 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: France 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 140: France Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: France 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Germany Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Germany 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Germany 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Germany 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Germany 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Italy Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Italy 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Italy 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Italy 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Italy 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 167: UK Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: UK Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: UK 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 170: UK Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: UK 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 173: UK Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: UK Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: UK 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 176: UK Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: UK Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: UK 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 179: Spain Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Spain Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Spain 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 182: Spain Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Spain Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Spain 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 185: Spain Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Spain Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Spain 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 188: Spain Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Spain Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Spain 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 191: Russia Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Russia Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Russia 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 194: Russia Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Russia Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Russia 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 197: Russia Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Russia Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Russia 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 200: Russia Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Russia Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Russia 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Europe Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Europe 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Europe Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Europe 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Europe Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Europe 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 212: Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Europe Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Europe 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Molecular Pharming by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Asia-Pacific 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Asia-Pacific Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Asia-Pacific 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Asia-Pacific Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Asia-Pacific 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 227: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Asia-Pacific Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Asia-Pacific 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 230: Australia Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Australia Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Australia 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 233: Australia Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Australia Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Australia 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 236: Australia Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Australia Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Australia 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 239: Australia Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Australia Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Australia 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 242: India Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: India Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: India 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 245: India Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: India Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: India 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 248: India Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: India Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: India 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 251: India Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: India Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: India 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 254: South Korea Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: South Korea Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: South Korea 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 257: South Korea Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: South Korea Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: South Korea 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 260: South Korea Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: South Korea Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: South Korea 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 263: South Korea Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: South Korea Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: South Korea 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Rest of Asia-Pacific Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Rest of Asia-Pacific Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Rest of Asia-Pacific Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 275: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Rest of Asia-Pacific Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Molecular Pharming by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: Latin America 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 281: Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Latin America Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Latin America 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 284: Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Latin America Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Latin America 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 287: Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Latin America Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Latin America 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 290: Latin America Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Latin America Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: Latin America 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 293: Argentina Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Argentina Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Argentina 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 296: Argentina Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Argentina Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Argentina 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 299: Argentina Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Argentina Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Argentina 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 302: Argentina Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Argentina Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Argentina 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 305: Brazil Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Brazil Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Brazil 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 308: Brazil Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Brazil Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Brazil 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 311: Brazil Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Brazil Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 313: Brazil 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 314: Brazil Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Brazil Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 316: Brazil 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 317: Mexico Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Mexico Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 319: Mexico 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 320: Mexico Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Mexico Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 322: Mexico 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 323: Mexico Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Mexico Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 325: Mexico 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 326: Mexico Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Mexico Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 328: Mexico 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Rest of Latin America Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 331: Rest of Latin America 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Rest of Latin America Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 334: Rest of Latin America 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Rest of Latin America Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 337: Rest of Latin America 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 338: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Rest of Latin America Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 340: Rest of Latin America 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Molecular Pharming by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 343: Middle East 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 344: Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Middle East Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 346: Middle East 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 347: Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Middle East Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 349: Middle East 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 350: Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Middle East Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 352: Middle East 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 353: Middle East Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Middle East Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 355: Middle East 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 356: Iran Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Iran Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 358: Iran 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 359: Iran Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Iran Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 361: Iran 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 362: Iran Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Iran Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 364: Iran 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 365: Iran Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Iran Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 367: Iran 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 368: Israel Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Israel Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 370: Israel 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 371: Israel Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Israel Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 373: Israel 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 374: Israel Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Israel Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 376: Israel 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 377: Israel Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Israel Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 379: Israel 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Saudi Arabia Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 382: Saudi Arabia 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Saudi Arabia Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 385: Saudi Arabia 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Saudi Arabia Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 388: Saudi Arabia 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 389: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Saudi Arabia Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 391: Saudi Arabia 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 392: UAE Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: UAE Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 394: UAE 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 395: UAE Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: UAE Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 397: UAE 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 398: UAE Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: UAE Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 400: UAE 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 401: UAE Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: UAE Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 403: UAE 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Rest of Middle East Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 406: Rest of Middle East 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Rest of Middle East Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 409: Rest of Middle East 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Rest of Middle East Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 412: Rest of Middle East 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 413: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Rest of Middle East Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 415: Rest of Middle East 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 416: Africa Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Africa Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 418: Africa 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
    • TABLE 419: Africa Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Africa Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 421: Africa 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
    • TABLE 422: Africa Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 423: Africa Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 424: Africa 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 425: Africa Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 426: Africa Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 427: Africa 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!